Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1350224

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1350224

Europe Digital Polymerase Chain Reaction (PCR) Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 235 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Europe Digital Polymerase Chain Reaction (PCR) market is expected to reach USD 3,568.36 million by 2030 from USD 1,694.69 million in 2022, growing at a CAGR of 10.4% during the forecast period of 2023 to 2033.

Market Segmentation

Europe Digital Polymerase Chain Reaction (PCR) Market, By Product Type (Digital PCR Instruments, Consumables and Reagents, and Software and Services), Technology (Droplet Digital PCR, Beaming Digital PCR), Application (Clinical, Life Science & Research, and Others), End Users (Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Organizations, Reference Laboratories and Others), Distribution Channel (Direct Tenders, Retail Sales, Others), Country (Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, and Rest of Europe) - Industry Trends and Forecast to 2030.

Overview of Europe Digital Polymerase Chain Reaction (PCR) Market Dynamics

  • Drivers
  • .
  • Rise in Availability of Digital PCR Diagnostics
  • Increasing Application of Digital PCR
  • Restraints
  • Limitations in Analyzing Novel Complex Devices
  • High Cost of Digital PCR Devices
  • Opportunity
  • Rising Product Innovations through Research and Development Activities

Market Players

Some of the major market players operating in the Europe digital polymerase chain reaction (PCR) market are:

  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • QIAGEN
  • Eppendorf SE
  • Sysmex Corporation
  • Stilla
  • RainSure Scientific
  • Accumax
  • Standard BioTools Inc
  • JN Medsys
  • VSI Electronics Pvt. Ltd
  • Precigenome LLC

TABLE OF CONTENTS

1 INTRODUCTION 54

  • 1.1 OBJECTIVES OF THE STUDY 54
  • 1.2 MARKET DEFINITION 54
  • 1.3 OVERVIEW OF THE EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET 54
  • 1.4 LIMITATIONS 56
  • 1.5 MARKETS COVERED 56

2 MARKET SEGMENTATION 59

  • 2.1 MARKETS COVERED 59
  • 2.2 GEOGRAPHICAL SCOPE 60
  • 2.3 YEARS CONSIDERED FOR THE STUDY 61
  • 2.4 CURRENCY AND PRICING 61
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 62
  • 2.6 MULTIVARIATE MODELLING 65
  • 2.7 PRODUCT TYPE LIFELINE CURVE 65
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
  • 2.9 DBMR MARKET POSITION GRID 67
  • 2.10 MARKET APPLICATION COVERAGE GRID 68
  • 2.11 VENDOR SHARE ANALYSIS 69
  • 2.12 SECONDARY SOURCES 70
  • 2.13 ASSUMPTIONS 70

3 EXECUTIVE SUMMARY 71

4 PREMIUM INSIGHTS 73

  • 4.1 PORTER'S FIVE FORCES 74
  • 4.2 PESTEL ANALYSIS 75
  • 4.3 MICRO AND MACRO ECONOMIC FACTORS 76
  • 4.4 PENETRATION AND GROWTH PROSPECT MAPPING 76
  • 4.5 KEY PRICING STRATEGIES 77

5 REGULATORY COMPLIANCE 78

  • 5.1 REGULATORY AUTHORITIES 78
  • 5.2 REGULATORY CLASSIFICATIONS 78
  • 5.3 REGULATORY SUBMISSIONS 78
  • 5.4 INTERNATIONAL HARMONIZATION 79
  • 5.5 COMPLIANCE AND QUALITY MANAGEMENT SCENARIO 80
  • 5.6 REGULATORY CHALLENGES AND STRATEGY 81
    • 5.6.1 REGULATORY SCENARIO IN EUROPE 81

6 MARKET OVERVIEW 82

  • 6.1 DRIVERS 84
    • 6.1.1 RISE IN AVAILABILITY OF DIGITAL PCR DIAGNOSTICS 84
    • 6.1.2 INCREASING APPLICATION OF DIGITAL PCR 84
    • 6.1.3 INCREASING DEMAND FOR PERSONALIZED MEDICINE 85
  • 6.2 RESTRAINTS 85
    • 6.2.1 LIMITATIONS IN ANALYZING NOVEL COMPLEX DEVICES 85
    • 6.2.2 HIGH COST OF DIGITAL PCR DEVICES 86
  • 6.3 OPPORTUNITIES 86
    • 6.3.1 RISING FREQUENCY OF INFECTIOUS DISEASES 86
    • 6.3.2 RISING PRODUCT INNOVATIONS THROUGH R&D ACTIVITIES 86
  • 6.4 CHALLENGES 87
    • 6.4.1 STRINGENT REGULATIONS AND LEGAL CHALLENGES FOR DIGITAL PCR 87
    • 6.4.2 LACK OF SKILLED PROFESSIONALS PERFORMING DIGITAL PCR 87

7 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY PRODUCT TYPE 89

  • 7.1 OVERVIEW 90
  • 7.2 DIGITAL PCR INSTRUMENTS 93
    • 7.2.1 BY MODALITY 93
      • 7.2.1.1 STANDLONE 93
      • 7.2.1.2 PORTABLE 93
    • 7.2.2 BY METHOD 93
      • 7.2.2.1 PLATE-BASED DPCR 94
      • 7.2.2.2 CHIP BASED DPCR 94
      • 7.2.2.3 MICROFLUIDIC CHAMBER BASED DPCR 94
      • 7.2.2.4 OTHERS 94
  • 7.3 CONSUMABLES AND REAGENTS 94
    • 7.3.1 REAGENTS 94
      • 7.3.1.1 DNA OR PCR TEMPLATES 95
      • 7.3.1.2 DNA POLYMERASE ENZYME 95
      • 7.3.1.3 PRIMERS 95
      • 7.3.1.4 DEXOYNUCLEOTIDE TRIPHOSPHATES (DNTPS) 95
      • 7.3.1.5 PCR BUFFERS 95
      • 7.3.1.6 PCR KIT 95 
    • 7.3.2 CONSUMABLES 96
      • 7.3.2.1 PLATES 96
      • 7.3.2.2 TUBES & CAPS 96
      • 7.3.2.3 PLASTIC ACCESSORIES 96
      • 7.3.2.4 PLATE SEALS 96
      • 7.3.2.5 CARTRIDGES 97
      • 7.3.2.6 OTHERS 97
  • 7.4 SOFTWARE AND SERVICES 97

8 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY TECHNOLOGY 98

  • 8.1 OVERVIEW 99
  • 8.2 DROPLET DIGITAL PCR 102
    • 8.2.1 CLINICAL 102
    • 8.2.2 LIFE SCIENCE & RESEARCH 102
    • 8.2.3 OTHERS 102
  • 8.3 BEAMING DIGITAL PCR 103
    • 8.3.1 CLINICAL 103
    • 8.3.2 LIFE SCIENCE & RESEARCH 103
    • 8.3.3 OTHERS 103

9 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY APPLICATION 104

  • 9.1 OVERVIEW 105
  • 9.2 CLINICAL 108
    • 9.2.1 ONCOLOGY TESTING 108
    • 9.2.2 INFECTIOUS DISEASE TESTING 108
      • 9.2.2.1 HIV 109
      • 9.2.2.2 HCV 109
      • 9.2.2.3 HEPATITIS B VIRUS 109
      • 9.2.2.4 HUMAN PAPILLOMAVIRUS 109
      • 9.2.2.5 OTHERS 109
    • 9.2.3 BLOOD SCREENING 109
    • 9.2.4 TRANSPLANT DIAGNOSTICS 109
  • 9.3 LIFE SCIENCE & RESEARCH 110
    • 9.3.1 MICROBIOLOGY 110
    • 9.3.2 MOLECULAR AND CELL BIOLOGY 110
    • 9.3.3 OTHERS 110
  • 9.4 OTHERS 110

10 EUROPE DIGITAL POLYMERASE CHAIN (PCR) REACTION MARKET, BY END USER 111

  • 10.1 OVERVIEW 112
  • 10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 115
  • 10.3 HOSPITALS AND CLINICS 115
    • 10.3.1 PRIVATE 115
      • 10.3.1.1 TIER 1 115
      • 10.3.1.2 TIER 2 116
      • 10.3.1.3 TIER 3 116
    • 10.3.2 PUBLIC 116
      • 10.3.2.1 TIER 1 116
      • 10.3.2.2 TIER 2 116
      • 10.3.2.3 TIER 3 116
  • 10.4 DIAGNOSTIC LABORATORIES 117
  • 10.5 ACADEMIC AND RESEARCH ORGANIZATIONS 117
  • 10.6 REFERENCE LABORATORIES 117
  • 10.7 OTHERS 117

11 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DISTRIBUTION CHANNEL 118

  • 11.1 OVERVIEW 119
  • 11.2 DIRECT TENDER 122
  • 11.3 RETAIL SALES 122
  • 11.4 OTHERS 122

12 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY REGION 123

  • 12.1 EUROPE 124

13 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, COMPANY LANDSCAPE 205

  • 13.1 COMPANY SHARE ANALYSIS: EUROPE 205

14 SWOT ANALYSIS 206

15 COMPANY PROFILE 207

  • 15.1 F. HOFFMANN- LA ROCHE LTD 207
    • 15.1.1 COMPANY SNAPSHOT 207
    • 15.1.2 REVENUE ANALYSIS 207
    • 15.1.3 COMPANY SHARE ANALYSIS 208
    • 15.1.4 PRODUCT PORTFOLIO 208
    • 15.1.5 RECENT DEVELOPMENT 208 
  • 15.2 BIO-RAD LABORATORIES, INC 209
    • 15.2.1 COMPANY SNAPSHOT 209
    • 15.2.2 REVENUE ANALYSIS 209
    • 15.2.3 COMPANY SHARE ANALYSIS 210
    • 15.2.4 PRODUCT PORTFOLIO 210
    • 15.2.5 RECENT DEVELOPMENTS 210
  • 15.3 MERCK KGAA 212
    • 15.3.1 COMPANY SNAPSHOT 212
    • 15.3.2 REVENUE ANALYSIS 212
    • 15.3.3 COMPANY SHARE ANALYSIS 213
    • 15.3.4 PRODUCT PORTFOLIO 213
    • 15.3.5 RECENT DEVELOPMENT 213
  • 15.4 THERMO FISHER SCIENTIFIC 214
    • 15.4.1 COMPANY SNAPSHOT 214
    • 15.4.2 REVENUE ANALYSIS 214
    • 15.4.3 COMPANY SHARE ANALYSIS 215
    • 15.4.4 PRODUCT PORTFOLIO 215
    • 15.4.5 RECENT DEVELOPMENTS 215
  • 15.5 QIAGEN 217
    • 15.5.1 COMPANY SNAPSHOT 217
    • 15.5.2 REVENUE ANALYSIS 217
    • 15.5.3 COMPANY SHARE ANALYSIS 218
    • 15.5.4 PRODUCT PORTFOLIO 218
    • 15.5.5 RECENT DEVELOPMENT 218
  • 15.6 ACCUMAX 220
    • 15.6.1 COMPANY SNAPSHOT 220
    • 15.6.2 PRODUCT PORTFOLIO 220
    • 15.6.3 RECENT DEVELOPMENT 220
  • 15.7 EPPENDORF SE 221
    • 15.7.1 COMPANY SNAPSHOT 221
    • 15.7.2 PRODUCT PORTFOLIO 221
    • 15.7.3 RECENT DEVELOPMENT 221
  • 15.8 JN MEDSYS 222
    • 15.8.1 COMPANY SNAPSHOT 222
    • 15.8.2 PRODUCT PORTFOLIO 222
    • 15.8.3 RECENT DEVELOPMENT 223
  • 15.9 PRECIGENOME LLC 224
    • 15.9.1 COMPANY SNAPSHOT 224
    • 15.9.2 PRODUCT PORTFOLIO 224
    • 15.9.3 RECENT DEVELOPMENT 224
  • 15.10 RAINSURE SCIENTIFIC 225
    • 15.10.1 COMPANY SNAPSHOT 225
    • 15.10.2 PRODUCT PORTFOLIO 225
    • 15.10.3 RECENT DEVELOPMENT 225
  • 15.11 STANDARD BIOTOOLS 226
    • 15.11.1 COMPANY SNAPSHOT 226
    • 15.11.2 REVENUE ANALYSIS 226
    • 15.11.3 PRODUCT PORTFOLIO 227
    • 15.11.4 RECENT DEVELOPMENT 227
  • 15.12 STILLA 228
    • 15.12.1 COMPANY SNAPSHOT 228
    • 15.12.2 PRODUCT PORTFOLIO 228
    • 15.12.3 RECENT DEVELOPMENT 228
  • 15.13 SYSMEX CORPORATION 229
    • 15.13.1 COMPANY SNAPSHOT 229
    • 15.13.2 REVENUE ANALYSIS 229
    • 15.13.3 PRODUCT PORTFOLIO 230
    • 15.13.4 RECENT DEVELOPMENT 230
  • 15.14 VSI ELECTRONICS PVT. LTD 231
    • 15.14.1 COMPANY SNAPSHOT 231
    • 15.14.2 PRODUCT PORTFOLIO 231
    • 15.14.3 RECENT DEVELOPMENT 231

16 QUESTIONNAIRE 232

17 RELATED REPORTS 235

LIST OF TABLES

  • TABLE 1 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 65
  • TABLE 2 EUROPE DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY MODALITY, 2021-2030 (USD MILLION) 66
  • TABLE 3 EUROPE DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY METHOD, 2021-2030 (USD MILLION) 66
  • TABLE 4 EUROPE CONSUMABLES AND REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
  • TABLE 5 EUROPE REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 68
  • TABLE 6 EUROPE CONSUMABLES IN DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 69
  • TABLE 7 EUROPE POLYMERASE CHAIN REACTION (PCR) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 74
  • TABLE 8 EUROPE DROPLET DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 75
  • TABLE 9 EUROPE DROPLET DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 76
  • TABLE 10 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 80
  • TABLE 11 EUROPE CLINICAL IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 81
  • TABLE 12 EUROPE INFECTIOUS DISEASE TESTING IN POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 81
  • TABLE 13 EUROPE LIFE SCIENCE AND RELATED RESEARCHES IN POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 83
  • TABLE 14 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END USER, 2021-2030 (USD MILLION) 87
  • TABLE 15 EUROPE HOSPITALS AND CLINICS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 88
  • TABLE 16 EUROPE PRIVATE IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 88
  • TABLE 17 EUROPE PUBLIC IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 89
  • TABLE 18 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 94
  • TABLE 19 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 97
  • TABLE 20 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 97
  • TABLE 21 EUROPE DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY MODALITY, 2021-2030 (USD MILLION) 98
  • TABLE 22 EUROPE DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY METHOD, 2021-2030 (USD MILLION) 98
  • TABLE 23 EUROPE CONSUMABLES AND REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 98
  • TABLE 24 EUROPE REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 99
  • TABLE 25 EUROPE CONSUMABLES IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 99
  • TABLE 26 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 99
  • TABLE 27 EUROPE DROPLET DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 100
  • TABLE 28 EUROPE BEAMING DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 100
  • TABLE 29 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 100
  • TABLE 30 EUROPE CLINICAL IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 100
  • TABLE 31 EUROPE INFECTIOUS DISEASE TESTING IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 101
  • TABLE 32 EUROPE LIFE SCIENCE & RESEARCH IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 101
  • TABLE 33 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END USER, 2021-2030 (USD MILLION) 101
  • TABLE 34 EUROPE HOSPITALS AND CLINICS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 102
  • TABLE 35 EUROPE PRIVATE IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 102
  • TABLE 36 EUROPE PUBLIC IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 102
  • TABLE 37 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 102
  • TABLE 38 GERMANY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 103
  • TABLE 39 GERMANY DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY MODALITY, 2021-2030 (USD MILLION) 103
  • TABLE 40 GERMANY DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY METHOD, 2021-2030 (USD MILLION) 103
  • TABLE 41 GERMANY CONSUMABLES AND REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 103
  • TABLE 42 GERMANY REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 104
  • TABLE 43 GERMANY CONSUMABLES IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 104
  • TABLE 44 GERMANY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 104
  • TABLE 45 GERMANY DROPLET DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 105
  • TABLE 46 GERMANY BEAMING DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 105
  • TABLE 47 GERMANY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 105
  • TABLE 48 GERMANY CLINICAL IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 105
  • TABLE 49 GERMANY INFECTIOUS DISEASE TESTING IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 106
  • TABLE 50 GERMANY LIFE SCIENCE & RESEARCH IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 106
  • TABLE 51 GERMANY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END USER, 2021-2030 (USD MILLION) 106
  • TABLE 52 GERMANY HOSPITALS AND CLINICS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 107
  • TABLE 53 GERMANY PRIVATE IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 107
  • TABLE 54 GERMANY PUBLIC IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 107
  • TABLE 55 GERMANY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 107
  • TABLE 56 FRANCE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 108
  • TABLE 57 FRANCE DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY MODALITY, 2021-2030 (USD MILLION) 108
  • TABLE 58 FRANCE DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY METHOD, 2021-2030 (USD MILLION) 108
  • TABLE 59 FRANCE CONSUMABLES AND REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 108
  • TABLE 60 FRANCE REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
  • TABLE 61 FRANCE CONSUMABLES IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
  • TABLE 62 FRANCE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 109
  • TABLE 63 FRANCE DROPLET DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 110
  • TABLE 64 FRANCE BEAMING DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 110
  • TABLE 65 FRANCE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 110
  • TABLE 66 FRANCE CLINICAL IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 110
  • TABLE 67 FRANCE INFECTIOUS DISEASE TESTING IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 111
  • TABLE 68 FRANCE LIFE SCIENCE & RESEARCH IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 111
  • TABLE 69 FRANCE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END USER, 2021-2030 (USD MILLION) 111
  • TABLE 70 FRANCE HOSPITALS AND CLINICS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 112
  • TABLE 71 FRANCE PRIVATE IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 112
  • TABLE 72 FRANCE PUBLIC IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 112
  • TABLE 73 FRANCE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 112
  • TABLE 74 U.K. DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
  • TABLE 75 U.K. DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY MODALITY, 2021-2030 (USD MILLION) 113
  • TABLE 76 U.K. DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY METHOD, 2021-2030 (USD MILLION) 113
  • TABLE 77 U.K. CONSUMABLES AND REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
  • TABLE 78 U.K. REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
  • TABLE 79 U.K. CONSUMABLES IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
  • TABLE 80 U.K. DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 114
  • TABLE 81 U.K. DROPLET DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
  • TABLE 82 U.K. BEAMING DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
  • TABLE 83 U.K. DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
  • TABLE 84 U.K. CLINICAL IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
  • TABLE 85 U.K. INFECTIOUS DISEASE TESTING IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 116
  • TABLE 86 U.K. LIFE SCIENCE & RESEARCH IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 116
  • TABLE 87 U.K. DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END USER, 2021-2030 (USD MILLION) 116
  • TABLE 88 U.K. HOSPITALS AND CLINICS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 117
  • TABLE 89 U.K. PRIVATE IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 117
  • TABLE 90 U.K. PUBLIC IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 117
  • TABLE 91 U.K. DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 117
  • TABLE 92 ITALY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 118
  • TABLE 93 ITALY DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY MODALITY, 2021-2030 (USD MILLION) 118
  • TABLE 94 ITALY DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY METHOD, 2021-2030 (USD MILLION) 118
  • TABLE 95 ITALY CONSUMABLES AND REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 118
  • TABLE 96 ITALY REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
  • TABLE 97 ITALY CONSUMABLES IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
  • TABLE 98 ITALY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 119
  • TABLE 99 ITALY DROPLET DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 120
  • TABLE 100 ITALY BEAMING DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 120
  • TABLE 101 ITALY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 120
  • TABLE 102 ITALY CLINICAL IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 120
  • TABLE 103 ITALY INFECTIOUS DISEASE TESTING IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 121
  • TABLE 104 ITALY LIFE SCIENCE & RESEARCH IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 121
  • TABLE 105 ITALY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END USER, 2021-2030 (USD MILLION) 121
  • TABLE 106 ITALY HOSPITALS AND CLINICS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 122
  • TABLE 107 ITALY PRIVATE IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 122
  • TABLE 108 ITALY PUBLIC IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 122
  • TABLE 109 ITALY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 122
  • TABLE 110 SPAIN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
  • TABLE 111 SPAIN DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY MODALITY, 2021-2030 (USD MILLION) 123
  • TABLE 112 SPAIN DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY METHOD, 2021-2030 (USD MILLION) 123
  • TABLE 113 SPAIN CONSUMABLES AND REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
  • TABLE 114 SPAIN REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 115 SPAIN CONSUMABLES IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 116 SPAIN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 124
  • TABLE 117 SPAIN DROPLET DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 125
  • TABLE 118 SPAIN BEAMING DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 125
  • TABLE 119 SPAIN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 125
  • TABLE 120 SPAIN CLINICAL IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 125
  • TABLE 121 SPAIN INFECTIOUS DISEASE TESTING IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 126
  • TABLE 122 SPAIN LIFE SCIENCE & RESEARCH IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 126
  • TABLE 123 SPAIN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END USER, 2021-2030 (USD MILLION) 126
  • TABLE 124 SPAIN HOSPITALS AND CLINICS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 125 SPAIN PRIVATE IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 126 SPAIN PUBLIC IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 127 SPAIN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 127
  • TABLE 128 RUSSIA DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 129 RUSSIA DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY MODALITY, 2021-2030 (USD MILLION) 128
  • TABLE 130 RUSSIA DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY METHOD, 2021-2030 (USD MILLION) 128
  • TABLE 131 RUSSIA CONSUMABLES AND REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 132 RUSSIA REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 133 RUSSIA CONSUMABLES IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 134 RUSSIA DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 129
  • TABLE 135 RUSSIA DROPLET DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 130
  • TABLE 136 RUSSIA BEAMING DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 130
  • TABLE 137 RUSSIA DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 130
  • TABLE 138 RUSSIA CLINICAL IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 130
  • TABLE 139 RUSSIA INFECTIOUS DISEASE TESTING IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
  • TABLE 140 RUSSIA LIFE SCIENCE & RESEARCH IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
  • TABLE 141 RUSSIA DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END USER, 2021-2030 (USD MILLION) 131
  • TABLE 142 RUSSIA HOSPITALS AND CLINICS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 143 RUSSIA PRIVATE IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 144 RUSSIA PUBLIC IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 145 RUSSIA DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 132
  • TABLE 146 TURKEY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 147 TURKEY DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY MODALITY, 2021-2030 (USD MILLION) 133
  • TABLE 148 TURKEY DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY METHOD, 2021-2030 (USD MILLION) 133
  • TABLE 149 TURKEY CONSUMABLES AND REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 150 TURKEY REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 151 TURKEY CONSUMABLES IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 152 TURKEY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 134
  • TABLE 153 TURKEY DROPLET DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
  • TABLE 154 TURKEY BEAMING DIGITAL PCR IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
  • TABLE 155 TURKEY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
  • TABLE 156 TURKEY CLINICAL IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
  • TABLE 157 TURKEY INFECTIOUS DISEASE TESTING IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
  • TABLE 158 TURKEY LIFE SCIENCE & RESEARCH IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
  • TABLE 159 TURKEY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END USER, 2021-2030 (USD MILLION) 136
  • TABLE 160 TURKEY HOSPITALS AND CLINICS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 161 TURKEY PRIVATE IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 162 TURKEY PUBLIC IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 163 TURKEY DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 137
  • TABLE 164 BELGIUM DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
  • TABLE 165 BELGIUM DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY MODALITY, 2021-2030 (USD MILLION) 138
  • TABLE 166 BELGIUM DIGITAL PCR INSTRUMENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY METHOD, 2021-2030 (USD MILLION) 138
  • TABLE 167 BELGIUM CONSUMABLES AND REAGENTS IN DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138

LIST OF FIGURES

  • FIGURE 1 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: SEGMENTATION 31
  • FIGURE 2 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: DATA TRIANGULATION 34
  • FIGURE 3 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: DROC ANALYSIS 35
  • FIGURE 4 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 36
  • FIGURE 5 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: COMPANY RESEARCH ANALYSIS 36
  • FIGURE 6 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: INTERVIEW DEMOGRAPHICS 38
  • FIGURE 7 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: DBMR MARKET POSITION GRID 39
  • FIGURE 8 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: MARKET APPLICATION COVERAGE GRID 40
  • FIGURE 9 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: VENDOR SHARE ANALYSIS 41
  • FIGURE 10 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: SEGMENTATION 44
  • FIGURE 11 RISE IN AVAILABILITY OF DIGITAL PCR DIAGNOSTICS AND INCREASING APPLICATION OF DIGITAL PCR IS EXPECTED TO DRIVE THE EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET IN THE FORECAST PERIOD 45
  • FIGURE 12 DIGITAL PCR INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET IN 2023 & 2030 45
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET 55
  • FIGURE 14 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY PRODUCT TYPE, 2022 62
  • FIGURE 15 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 63
  • FIGURE 16 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 63
  • FIGURE 17 EUROPE DIGITAL POLYMERASE CHAIN (PCR) REACTION MARKET: BY PRODUCT TYPE, LIFELINE CURVE 64
  • FIGURE 18 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET: BY TECHNOLOGY, 2022 71
  • FIGURE 19 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION) 72
  • FIGURE 20 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET: BY TECHNOLOGY, CAGR (2023-2030) 72
  • FIGURE 21 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET: BY TECHNOLOGY, LIFELINE CURVE 73
  • FIGURE 22 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY APPLICATION, 2022 77
  • FIGURE 23 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 78
  • FIGURE 24 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY APPLICATION, CAGR (2023-2030) 78
  • FIGURE 25 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY APPLICATION, LIFELINE CURVE 79
  • FIGURE 26 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY END USER, 2022 84
  • FIGURE 27 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY END USER, 2023-2030 (USD MILLION) 85
  • FIGURE 28 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY END USER, CAGR (2023-2030) 85
  • FIGURE 29 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY END USER, LIFELINE CURVE 86
  • FIGURE 30 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY DISTRIBUTION CHANNEL, 2022 91
  • FIGURE 31 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 92
  • FIGURE 32 EUROPE POLYMERASE CHAIN REACTION (PCR) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 92
  • FIGURE 33 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 93
  • FIGURE 34 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET: COMPANY SHARE 2022 (%) 177
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!